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Originating Technology/NASA Contribution
Among NASA’s research goals is increased understanding of factors affecting plant growth, including the effects of microgravity. Impeding 
such studies, traditional light sources used to grow plants 
on Earth are difficult to adapt to space flight, as they 
require considerable amounts of power and produce 
relatively large amounts of heat. As such, an optimized 
experimental system requires much less energy and 
reduces temperature variance without negatively affecting 
plant growth results.
Ronald W. Ignatius, founder and chairman of the 
board at Quantum Devices Inc. (QDI), of Barneveld, 
Wisconsin, proposed using light-emitting diodes (LEDs) 
as the photon source for plant growth experiments in 
space. This proposition was made at a meeting held 
by the Wisconsin Center for Space Automation and 
Robotics, a NASA-sponsored research center that 
facilitates the commercialization of robotics, automation, 
and other advanced technologies. The Wisconsin group 
teamed with QDI to determine whether an LED system 
could provide the necessary wavelengths and intensities 
for photosynthesis, and the resultant system proved 
successful. The center then produced the Astroculture3, a 
plant growth chamber that successfully incorporated this 
LED light source, which has now flown on several space 
shuttle missions.
NASA subsequently identified another need that could 
be addressed with the use of LEDs: astronaut health. 
A central concern in astronaut health is maintaining 
healthy growth of cells, including preventing bone 
and muscle loss and boosting the body’s ability to heal 
wounds—all adversely affected by prolonged weightless-
ness. Thus, having determined that LEDs can be used 
to grow plants in space, NASA decided to investigate 
whether LEDs might be used for photobiomodulation 
therapy (PBMT). 
PBMT is an emerging medical and veterinary technique 
in which exposure to high-intensity, wavelength-specific 
light can stimulate or inhibit cellular function. PBMT 
modulates a body’s organelles—structures within a cell 
(e.g., mitochondria, vacuoles, and chloroplasts) that store 
food, discharge waste, produce energy, or perform other 
functions analogous to the role of organs in the body 
as a whole—with wavelength-specific photon energy 
to increase respiratory metabolism, reduce the natural 
inflammatory response, accelerate recovery of injury or 
stress at the cellular level, and increase circulation.
Partnership
A NASA Small Business Innovation Research 
(SBIR) contract was granted to QDI to develop an LED 
light source for use in a surgical environment as the 
photon source for its proprietary Photodynamic Therapy 
(PDT) treatment. An emerging cancer treatment, PDT 
requires high-intensity, monochromatic light to turn on 
the cancer-killing properties of a drug, allowing physicians 
to activate a drug in the tumor only. 
QDI and Dr. Harry T. Whelan of the Medical College 
of Wisconsin (known for groundbreaking research in 
PBMT) based their work on QDI’s High Emissivity 
Aluminiferous Light-emitting Substrate (HEALS) 
technology, which was developed for use in the plant 
growth experiments in 1993. Several SBIR contracts from 
NASA’s Marshall Space Flight Center between 1995 and 
1998 helped QDI continue the evolution of HEALS 
in collaboration with Whelan, and the technology was 
successfully applied in cases of pediatric brain tumors and 
the prevention of oral mucositis in pediatric bone marrow 
transplant patients.
QDI then used a Defense Advanced Research Projects 
Agency (DARPA) SBIR contract to develop the WARP 10 
(Warfighter Accelerated Recovery by Photobiomodulation) 
unit as a full realization of its PBMT research. WARP 
10, a hand-held, portable, HEALS technology originally 
intended for military first aid applications, received U.S. 
Food and Drug Administration (FDA) clearance in 2003, 
and a consumer version was introduced for temporary 
relief of minor muscle and joint pain. WARP 10 has been 
found to relieve arthritis, muscle spasms, and stiffness; 
promote relaxation of tissue; and temporarily increase 
local blood circulation.
LED Device illuminates new path to Healing
Studies have shown red LEDs are a viable light source for 
growing plants in space flight due to their small mass and 
volume, wavelength specificity, longevity, and safe operation.
https://ntrs.nasa.gov/search.jsp?R=20090002502 2019-08-30T06:02:40+00:00Z
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Product Outcome
Since HEALS and WARP 10 were originally profiled 
in Spinoff 2005, a flurry of activity has seen this unique 
technology showered in awards and the next-generation 
LED device gain FDA clearance and enter the market. 
The HEALS and WARP 10 technologies have 
accrued an impressive résumé; the list of accolades 
received includes induction into the Space Technology 
Hall of Fame in 2000; being named a Marshall Space 
Flight Center “Hallmark of Success” as an outstanding 
commercialization of an SBIR-developed technology 
in 2004; and winning first place in the Wisconsin 
“Governor’s New Product Awards” in 2005 for the 
development of WARP 10. The greatest and most recent 
accolade came in 2006, when QDI was nominated for 
and received a “Tibbetts Award.” 
Named for Roland Tibbetts, the acknowledged 
“father of the SBIR program,” it is an annual govern-
ment-wide award for small firms, projects, organizations, 
and individuals judged to exemplify the very best in 
SBIR achievement. These prestigious national awards 
emphasize recognizing those accomplishments where, in 
the judgment of those closely involved and often most 
immediately affected, the stimulus of SBIR funding has 
made an important and definable difference. Economic 
impact of technological innovation, business achievement, 
effective collaborations, demonstrated state and regional 
impact, and proven support are the main considerations.
On the heels of this honor, 2007 saw FDA clearance 
for the new WARP 75 device, the latest iteration of the 
technology that began with the HEALS technology. The 
WARP 75 improves on the WARP 10 design, boasting 
7.5 times the actual coverage area of the WARP 10 
(75cm2 versus 10cm2), an automatic timed cycle of 88 
seconds with an audible alarm, AC power, the ability 
to be mounted on an articulated arm, and fan cooling. 
System controls are located on the top panel for easy light 
dose delivery, and the device is placed directly against 
the skin where treatment is desired. The unit can be 
operated with one hand and remains cool to the touch 
during operation.
The WARP 75 continues the legacy of its predecessors 
in clinical trials with the Medical College of Wisconsin 
and the University of Alabama at Birmingham for the 
amelioration of oral mucositis pain in bone marrow 
transplant patients. QDI is exploring other medical 
applications of the HEALS-based technology, includ-
ing combating the symptoms of bone atrophy, multiple 
sclerosis, diabetic complications, Parkinson’s disease, and 
a variety of ocular applications. Most recently, Marshall 
awarded QDI another grant to study synergistic wound 
healing and conduct a PDT study with silver nanoclus-
ters. Through all of their work, QDI remains dedicated 
to the principle that light provides the power for all life 
on Earth, and the belief that the quality, delivery, and 
control of light is essential to the wellness of the human 
race and our advancement into the future. v
HEALS®, WARP 10®, and WARP 75® are registered trademarks, 
and Photodynamic Therapy™ is a trademark of Quantum Devices 
Inc.
The WARP 75 (left) has 7.5 times more coverage area than the previously developed WARP 10 (right). The FDA has cleared 
the WARP 75 for the treatment of chronic pain, including the temporary relief of minor muscle and joint pain, arthritis, muscle 
spasms, and stiffness, by promoting relaxation of muscle tissue and temporarily increasing local blood circulation.
